| Date Filed | Type | Description |
| 08/07/2023 |
4
| Franchi Jean M. (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Granted 61,728 shares
@ $1.62, valued at
$100k
|
|
| 05/25/2023 |
4
| Franchi Jean M. (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Granted 40,422 restricted stock units
@ $0 |
|
| 05/18/2023 |
4
| Franchi Jean M. (CFO) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 11,351 shares
@ $18.05, valued at
$204.9k
|
|
| 04/04/2023 |
4
| Franchi Jean M. (CFO) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 45,000 shares
@ $0
Granted 67,500 options to buy
@ $17.66, valued at
$1.2M
|
|
| 01/05/2023 |
4
| Franchi Jean M. (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Granted 7,317 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Franchi Jean M. (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Granted 62,500 restricted stock units
@ $0 |
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Franchi Jean M. (CFO) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 3,436 shares
@ $14.59, valued at
$50.1k
|
|
| 04/05/2022 |
4
| Franchi Jean M. (CFO) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 52,500 shares
@ $0
Granted 78,750 options to buy
@ $18.26, valued at
$1.4M
|
|
| 04/04/2022 |
4
| Franchi Jean M. (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Exercised 20,044 restricted stock units
@ $0 |
|
| 07/01/2021 |
4
| Franchi Jean M. (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Granted 20,044 restricted stock units
@ $0 |
|
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Franchi Jean M. (CFO) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 17,856 shares
@ $43.7, valued at
$780.3k
Sold 6,755 shares
@ $42.86, valued at
$289.5k
Sold 389 shares
@ $42.09, valued at
$16.4k
Exercised 25,000 options to buy
@ $14.08, valued at
$352k
|
|
| 10/27/2020 |
3
| Franchi Jean M. (Director) has filed a Form 3 on BIODESIX INC |
| 04/02/2020 |
4
| Franchi Jean M. (CFO) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 56,350 options to buy
@ $9.78, valued at
$551.1k
|
|
| 12/11/2019 |
4
| Franchi Jean M. (CFO) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 180,000 options to buy
@ $14.08, valued at
$2.5M
|
|
| 12/11/2019 |
3
| Franchi Jean M. (CFO) has filed a Form 3 on Replimune Group, Inc. |
| 12/13/2018 |
4
| Franchi Jean M. (CFO) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Granted 45,000 options to buy
@ $4.15, valued at
$186.8k
|
|
| 02/16/2018 |
4
| Franchi Jean M. (CFO) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Granted 45,000 options to buy
@ $10.74, valued at
$483.3k
|
|
| 08/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/28/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |